TG003
Catalog No: 110226
CAS Number: 300801-52-9
Purity: 98%
TG003 is a novel benzothiazole compound that demonstrates potent inhibition of Clk1/Sty and Clk4 with IC50 values of 20 and 15 nM, respectively, which exhibits considerably weaker inhibition of Clk2 and Clk3 (IC50 = 200 nM and >10 M, respectively).
For research use only. We do not sell to patients.
Chemical Information
| Name | TG003 |
|---|---|
| Iupac Chemical Name | (1Z)-1-(3-ethyl-5-methoxy-1,3-benzothiazol-2-ylidene)propan-2-one |
| Synonyms | TG 003; TG-003; Clk Inhibitor, TG003; Cdc2-Like Kinase Inhibitor |
| Molecular Formula | C12H15NO2S |
| Molecular Weight | 237.318 |
| Smile | CCN1C2=C(C=CC(=C2)OC)SC1=CC(=O)C |
| InChiKey | BGVLELSCIHASRV-UHFFFAOYSA-N |
| InChi | InChI=1S/C13H15NO2S/c1-4-14-11-8-10(16-3)5-6-12(11)17-13(14)7-9(2)15/h5-8H,4H2,1-3H3 |
| CAS Number | 300801-52-9 |
| Related CAS |
Ordering Information
| Packaging | Price | Availability | Purity | Shipping Time |
|---|---|---|---|---|
| Bulk | Enquiry | Enquiry | Enquiry |
| Formulation | Solid powder |
|---|---|
| Purity | 98% |
| Storage | -20 ºC for 3 years |
| Solubility | Soluble in DMSO |
| Handling | |
| Shipping Condition | Shipped under ambient temperature |
| HS Code |
Coming soon.
| Targets | |
|---|---|
| Mechanism | |
| Cell study | |
| Animal study | |
| Clinical study |
Not available
Chemical Structure
